Multi-Modal Imaging Platforms in Preclinical Research
Small Animal Imaging is increasingly leveraging multi-modal imaging platforms that combine complementary techniques to provide comprehensive insights into biological processes. These platforms integrate anatomical, functional, and molecular imaging in a single system, enabling a holistic view of disease progression and therapeutic effects.
For example, PET/CT and PET/MRI systems allow simultaneous acquisition of high-resolution anatomical images alongside functional or metabolic data. Optical imaging can be combined with micro-CT or micro-MRI to track molecular changes in tumors or organs while maintaining precise anatomical context. The integration of these modalities enables researchers to extract richer data, improving the accuracy of preclinical models.
Multi-modal imaging platforms are particularly valuable in oncology research, where the interplay between tumor growth, angiogenesis, and immune responses can be studied comprehensively. Similarly, cardiovascular, neurological, and metabolic disease studies benefit from the ability to correlate structural changes with functional outcomes.
The use of multi-modal platforms also reduces experimental variability by allowing repeated measurements within the same animal. Advanced software tools provide automated image registration, quantitative analysis, and 3D visualization, streamlining workflow and accelerating data interpretation.
As multi-modal imaging technologies continue to evolve, their adoption will expand in drug discovery, biomarker validation, and translational research, ultimately bridging the gap between preclinical findings and clinical applications.